BIOLASE Holds Annual Meeting of Stockholders
11 Mayo 2012 - 8:00AM
Marketwired
BIOLASE Technology, Inc. (NASDAQ: BLTI)
- Four Directors Elected with More than 98 Percent of Shares
Voted at the Meeting
- Name of Corporation to Change to BIOLASE, Inc., from BIOLASE
Technology, Inc.
- Stock Dividend Declared for 2012 Second Quarter
BIOLASE Technology, Inc. (NASDAQ: BLTI), the World's leading
dental laser manufacturer and distributor, today announced that it
held its Annual Meeting of Stockholders on Thursday, May 10, at the
Company's corporate headquarters in Irvine, CA, as scheduled. A
quorum representing more than 80 percent of stockholders was
present in person or by proxy, and all proposals submitted were
approved.
The four directors elected with more than 98 percent of shares
voted at the meeting to serve until the next annual meeting are
Chairman and CEO Federico Pignatelli; Alexander K. Arrow, M.D., CFO
of Redwood City, CA-based Arstasis, Inc.; Gregory E. Lichtwardt,
Executive Vice President, Operations, Treasurer and CFO of
Conceptus, Inc.; and Norman J. Nemoy, M.D., a partner of Tower
Urology Medical Group.
The amendment to the Restated Certificate of Incorporation of
BIOLASE Technology, Inc. to change the name of the corporation to
BIOLASE, Inc. was approved. The name change will be effective after
the filing of the amended and Restated Certificate of
Incorporation. Other approved proposals include the appointment of
BDO USA, LLP as the Company's independent registered public
accounting firm; an advisory vote on the compensation of the
Company's named executive officers; and an advisory vote on the
frequency of future stockholder advisory votes on the compensation
of the named executive officers.
In addition, the Board of Directors has declared a one-half
percent stock dividend payable on June 25, 2012, to stockholders of
record on June 8, 2012.
About BIOLASE, Inc. BIOLASE, Inc., the
World's leading Dental Laser Company, is a medical technology
company that develops, manufactures and markets dental lasers and
also distributes and markets dental imaging equipment; products
that are focused on technologies that advance the practice of
dentistry and medicine. The Company's laser products incorporate
approximately 285 patented and patent pending technologies designed
to provide clinically superior performance with less pain and
faster recovery times. Its imaging products provide cutting-edge
technology at competitive prices to deliver the best results for
dentists and patients. BIOLASE's principal products are dental
laser systems that perform a broad range of dental procedures,
including cosmetic and complex surgical applications, and a full
line of dental imaging equipment. BIOLASE has sold more than 19,600
lasers among 16,000 customers. Other products under development
address ophthalmology and other medical and consumer markets.
For updates and information on laser and Waterlase dentistry,
find BIOLASE at http://www.biolase.com, Twitter at
http://twitter.com/GoWaterlase, and YouTube at
http://www.youtube.com/user/Rossca08.
This press release may contain forward-looking statements within
the meaning of safe harbor provided by the Securities Reform Act of
1995 that are based on the current expectations and estimates by
our management. These forward-looking statements can be identified
through the use of words such as "anticipates," "expects,"
"intends," "plans," "believes," "seeks," "estimates," "may,"
"will," and variations of these words or similar expressions.
Forward-looking statements are based on management's current,
preliminary expectations and are subject to risks, uncertainties
and other factors which may cause the Company's actual results to
differ materially from the statements contained herein, and are
described in the Company's reports it files with the Securities and
Exchange Commission, including its annual and quarterly reports. No
undue reliance should be placed on forward-looking statements. Such
information is subject to change, and we undertake no obligation to
update such statements.
For further information, please contact: Jill Bertotti Allen
& Caron +1-949-474-4300 jill@allencaron.com
Biolase (NASDAQ:BLTI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Biolase (NASDAQ:BLTI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024